Pharmaceutical Market Europe • July/August 2026 • 19
THOUGHT LEADER
By Vivienne Hanrahan
Healthcare communications are most impactful when science and human experience come together, but for teams responsible for healthcare strategy, this is proving to be one of their biggest challenges. Creativity is often developed through clinical, commercial or brand lenses, with patients, caregivers and healthcare professionals (HCPs) involved only after the core idea has been established.
This results in content that is accurate but misses what living with the condition actually feels like. By involving patients, caregivers and HCPs early in creative and innovation processes, we can uncover unmet needs, build trust and create more meaningful communication across the care journey.
At Amiculum, we are passionate advocates of co-creation – an approach embodied by this article. We brought together colleagues from patient engagement, medical communications, rare diseases, medical marketing and creative branding to discuss how patients, caregivers and HCPs can contribute to creative development.
One theme emerged repeatedly: patient inclusion doesn’t just improve ideas; it changes the ideas generated.
Some of the most powerful creative concepts emerge from lived experience. Patients and caregivers often describe their experiences using language and priorities that differ significantly from those used by clinicians, researchers and marketers.
Rather than incorporating patient insights at the end of a project, patient involvement can inform the creative foundation itself, resulting in messaging that feels more human, brings nuance to disease burden and introduces perspectives unlikely to emerge through traditional planning processes, as Amiculum’s Creative Director, Paula Holt, explains: “When all of this cleverly comes together, that is when making a difference through design becomes exciting. By bringing patients and caregivers into the conversation early, we can combine scientific accuracy with genuine human insight to create campaigns that are meaningful and deliver the desired outcome.”
Patients and caregivers experience healthcare differently from HCPs and industry stakeholders, and often identify challenges that may be overlooked during strategy development.
The Patients Association published findings from their 2026 patient experience article, noting that:
69% of patients were never asked what matters to them during their NHS care
Just 17% said their priorities were listened to and acted upon
Only 41% felt like an equal partner in decisions about their care.
These perspectives create opportunities for new ways of thinking. By understanding what matters most to people living with a condition, organisations can rethink established approaches and develop creative solutions that are more relevant to real-world needs.
Trust is one of the most valuable outcomes of patient engagement. When ideation is conducted with patients rather than for patients, the outputs are more likely to feel representative of the communities they are intended to benefit.
This distinction between consultation and co-creation is important. While feedback on completed materials can provide useful validation, engagement occurs when patients influence the direction of the work from the beginning.
When people recognise their own experiences in communications, trust grows. Communications become more than scientifically accurate; they become personally relevant.
Patient-informed creativity benefits more than patients alone. It helps HCPs communicate more effectively and supports shared decision-making.
Educational materials informed by patient perspectives help clinicians better understand what matters most to the people they treat, explain treatment options more clearly and facilitate more meaningful conversations. In turn, patients are better equipped to participate in decisions about their care.
This strengthens understanding and keeps communication focused on outcomes that matter in everyday life.
While this article has focused on how patients, caregivers and HCPs working together can enhance creativity and innovation, the greatest opportunities lie further upstream.
Patient involvement is often discussed within individual activities, such as reviewing materials, informing market research or contributing to creative concepts. However, the greatest value is realised when patient insights are embedded from the earliest stages of decision-making and carried throughout the product life cycle.
In a recent rare disease project, patient advocacy group co-researchers identified aspects of symptom burden on families that had not been raised by other stakeholders. This broadened the research scope and revealed new areas to explore.
While the findings are still being analysed, this illustrates how caregiver perspectives can influence decision-making and spark creative thinking, leading to different solutions rather than simply refining existing plans.
The most powerful outcomes are achieved when the patient voice is not simply heard, but is actively involved in generating future developments.
Patricia Jones is Client Partnership Team Lead and Patient Engagement Specialist at Amiculum